RTW INVESTMENTS, LP Diversified Active

Location: New York, NY

CIK: 0001493215 · Show all filings

Period: Q4 2016 (← Previous) (Next →)

Filing Date: Feb 15, 2017

Total Value: $266M (100.0% shares, 0.0% debt)

Holdings (32)

— Avexis Inc 15.3%

Value $40.52M Shares 849,043 Est. Cost $33.55 Unrealized —

BMY Bristol Myers Squibb Co 12.4%

Value $33.07M Shares 565,888 Est. Cost $42.72 Unrealized -7.5%

ALNY Alnylam Pharmaceuticals Inc 11.1%

Value $29.55M Shares 789,208 Est. Cost $86.12 Unrealized -51.4%

BCRX Biocryst Pharmaceuticals 9.7%

Value $25.82M Shares 4,078,895 Est. Cost $7.25 Unrealized -28.2%

— La Jolla Pharmaceutical Co 7.2%

Value $19.04M Shares 1,086,037 Est. Cost $25.02 Unrealized —

— Agenus Inc 6.5%

Value $17.35M Shares 4,210,264 Est. Cost $7.60 Unrealized —

— Medicines Co 4.8%

Value $12.7M Shares 374,263 Est. Cost $35.19 Unrealized —

PTCT PTC Therapeutics Inc 4.1%

Value $10.88M Shares 997,166 Est. Cost $10.49 Unrealized 0.0%

INCY Incyte Corp 3.3%

Value $8.699M Shares 86,757 Est. Cost $74.63 Unrealized +30.7%

— Oxford Immunotec Global PLC 3.1%

Value $8.122M Shares 543,287 Est. Cost $13.91 Unrealized —

— United States Oil Fund LP 3.0%

Value $7.911M Shares 675,000 Est. Cost $11.72 Unrealized —

— bluebird bio Inc 2.8%

Value $7.563M Shares 122,576 Est. Cost $48.74 Unrealized —

— Dicerna Pharmaceuticals Inc 2.2%

Value $5.884M Shares 2,043,216 Est. Cost $13.12 Unrealized —

MASI Masimo Corp 2.1%

Value $5.453M Shares 80,900 Est. Cost $54.87 Unrealized +12.0%

— Atara Biotherapeutics Inc 2.0%

Value $5.291M Shares 372,624 Est. Cost $14.20 Unrealized —

— Corium Intl Inc 1.7%

Value $4.47M Shares 1,101,045 Est. Cost $9.09 Unrealized —

RGNX Regenxbio Inc 1.7%

Value $4.448M Shares 239,789 Est. Cost $24.07 Unrealized -20.6%

— Viveve Med Inc 1.6%

Value $4.324M Shares 839,666 Est. Cost $4.19 Unrealized —

TCMD Tactile Sys Technology Inc 1.5%

Value $4.082M Shares 248,762 Est. Cost $15.52 Unrealized +11.7%

— Invuity Inc 1.0%

Value $2.616M Shares 454,900 Est. Cost $12.22 Unrealized —

OMER Omeros Corp 1.0%

Value $2.57M Shares 259,039 Est. Cost $14.29 Unrealized -28.6%

— Achillion Pharmaceuticals In 0.4%

Value $1.182M Shares 286,285 Est. Cost $10.21 Unrealized —

— Celldex Therapeutics Inc New 0.3%

Value $848K Shares 239,662 Est. Cost $12.18 Unrealized —

SRTS Sensus Heatlhcare Inc 0.2%

Value $645K Shares 122,803 Est. Cost $6.26 Unrealized -6.2%

— Mirati Therapeutics Inc 0.2%

Value $616K Shares 129,697 Est. Cost $33.11 Unrealized —

— Biopharmx Corp 0.2%

Value $476K Shares 1,273,128 Est. Cost $1.20 Unrealized —

— Global Blood Therapeutics In 0.1%

Value $375K Shares 25,963 Est. Cost $35.72 Unrealized —

NTRA Natera Inc 0.1%

Value $371K Shares 31,693 Est. Cost $16.90 Unrealized -34.9%

— Audentes Therapeutics Inc 0.1%

Value $365K Shares 20,000 Est. Cost $17.80 Unrealized —

— Mannkind Corp 0.1%

Value $279K Shares 438,500 Est. Cost — Unrealized —

— Sensus Heatlhcare Inc 0.0%

Value $78,000 Shares 155,000 Est. Cost $0.50 Unrealized —

— Nivalis Therapeutics Inc 0.0%

Value $67,000 Shares 30,000 Est. Cost $15.17 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Avexis Inc	849,043	$40.52M	15.3%	$33.55	—	COM	05366U100
BMY	Bristol Myers Squibb Co	565,888	$33.07M	12.4%	$42.72	-7.5%	COM	110122108
ALNY	Alnylam Pharmaceuticals Inc	789,208	$29.55M	11.1%	$86.12	-51.4%	COM	02043Q107
BCRX	Biocryst Pharmaceuticals	4,078,895	$25.82M	9.7%	$7.25	-28.2%	COM	09058V103
—	La Jolla Pharmaceutical Co	1,086,037	$19.04M	7.2%	$25.02	—	COM PAR $.0001 2	503459604
—	Agenus Inc	4,210,264	$17.35M	6.5%	$7.60	—	COM NEW	00847G705
—	Medicines Co	374,263	$12.7M	4.8%	$35.19	—	COM	584688105
PTCT	PTC Therapeutics Inc	997,166	$10.88M	4.1%	$10.49	0.0%	COM	69366J200
INCY	Incyte Corp	86,757	$8.699M	3.3%	$74.63	+30.7%	COM	45337C102
—	Oxford Immunotec Global PLC	543,287	$8.122M	3.1%	$13.91	—	ORD SHS	G6855A103
—	United States Oil Fund LP	675,000	$7.911M	3.0%	$11.72	—	UNITS	91232N108
—	bluebird bio Inc	122,576	$7.563M	2.8%	$48.74	—	COM	09609G100
—	Dicerna Pharmaceuticals Inc	2,043,216	$5.884M	2.2%	$13.12	—	COM	253031108
MASI	Masimo Corp	80,900	$5.453M	2.1%	$54.87	+12.0%	COM	574795100
—	Atara Biotherapeutics Inc	372,624	$5.291M	2.0%	$14.20	—	COM	046513107
—	Corium Intl Inc	1,101,045	$4.47M	1.7%	$9.09	—	COM	21887L107
RGNX	Regenxbio Inc	239,789	$4.448M	1.7%	$24.07	-20.6%	COM	75901B107
—	Viveve Med Inc	839,666	$4.324M	1.6%	$4.19	—	COM NEW	92852W204
TCMD	Tactile Sys Technology Inc	248,762	$4.082M	1.5%	$15.52	+11.7%	COM	87357P100
—	Invuity Inc	454,900	$2.616M	1.0%	$12.22	—	COM NEW	46187J205
OMER	Omeros Corp	259,039	$2.57M	1.0%	$14.29	-28.6%	COM	682143102
—	Achillion Pharmaceuticals In	286,285	$1.182M	0.4%	$10.21	—	COM	00448Q201
—	Celldex Therapeutics Inc New	239,662	$848K	0.3%	$12.18	—	COM	15117B103
SRTS	Sensus Heatlhcare Inc	122,803	$645K	0.2%	$6.26	-6.2%	COM	81728J109
—	Mirati Therapeutics Inc	129,697	$616K	0.2%	$33.11	—	COM	60468T105
—	Biopharmx Corp	1,273,128	$476K	0.2%	$1.20	—	COM	09072X101
—	Global Blood Therapeutics In	25,963	$375K	0.1%	$35.72	—	COM	37890U108
NTRA	Natera Inc	31,693	$371K	0.1%	$16.90	-34.9%	COM	632307104
—	Audentes Therapeutics Inc	20,000	$365K	0.1%	$17.80	—	COM	05070R104
—	Mannkind Corp	438,500	$279K	0.1%	—	—	Put	56400P201
—	Sensus Heatlhcare Inc	155,000	$78,000	0.0%	$0.50	—	WARRANTS EXP 12/31/2019	81728J117
—	Nivalis Therapeutics Inc	30,000	$67,000	0.0%	$15.17	—	COM	65481J109